JCM
LGND icon

Janney Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Janney Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$452K Buy
2,393
+43
+2% +$8.26K 0.03% 176
2025
Q3 		$416K Sell
2,350
-1,339
-36% -$199K 0.03% 174
2025
Q2 		$419K Sell
3,689
-480
-12% -$51.3K 0.03% 168
2025
Q1 		$438K Sell
4,169
-398
-9% -$45K 0.03% 164
2024
Q4 		$489K Buy
4,567
+7
+0.2% +$791 0.03% 172
2024
Q3 		$456K Sell
4,560
-1,273
-22% -$128K 0.03% 163
2024
Q2 		$491K Buy
+5,833
New +$464K 0.03% 156

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Janney Capital Management's LGND Position: Q4 2025 in Review

Janney Capital Management increased its Ligand Pharmaceuticals (LGND) stake by 1.8% in Q4 2025, buying an estimated $8.26K and bringing the position to 2,393 shares worth $452K. The position accounts for 0.03% of the portfolio, ranked #176.

Janney Capital Management first reported a position in LGND in Q2 2024 and has held it in 7 quarters since. The position peaked at $491K in Q2 2024. 349 funds tracked by Wall St. Rank hold LGND as of Q4 2025.

  • Janney Capital Management held 2,393 shares of Ligand Pharmaceuticals worth $452K as of Q4 2025.
  • Janney Capital Management bought 43 Ligand Pharmaceuticals shares in Q4 2025, an estimated $8.26K.
  • Ligand Pharmaceuticals made up 0.03% of Janney Capital Management's portfolio in Q4 2025, its #176 holding.
  • Janney Capital Management first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • Janney Capital Management's Ligand Pharmaceuticals position peaked at $491K in Q2 2024.
  • 349 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2025.

Based on Janney Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.